Development of CD388 AS a Long-Lasting Prophylactic Anti-Viral Option for Protection Against the Health Impacts Caused by Influenza
Contract Overview
Contract Amount: $58,051,983 ($58.1M)
Contractor: Cidara Therapeutics Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2025-09-30
End Date: 2027-09-29
Contract Duration: 729 days
Daily Burn Rate: $79.6K/day
Official Description: DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
Place of Performance
Location: California, 92121